Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Sarta

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphomaMuhammad R Abbasi, Joseph A Sparano, Catherine Sarta, et al.
The Laryngoscope|January 10, 2013
Transoral robotic total laryngectomyRichard V Smith, Bradley A Schiff, Catherine Sarta, et al.
Head & Neck|March 11, 2008
High-dose-rate brachytherapy plus neck dissection for nodal diseaseJonathan J Beitler, Madhur Garg, Randall P Owen, et al.
Oral Oncology|July 30, 2013
Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse populationAshish A Ankola, Richard V Smith, Robert D Burk, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 14, 2015
Randomized Controlled Trial Assessing the Feasibility of Shortened Fasts in Intubated ICU Patients Undergoing TracheotomyNathan Gonik, Andrew Tassler, Thomas J Ow, et al.
Clinical Breast Cancer|March 17, 2004
Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancerJoshua P Raff, Lakshmi Rajdev, Umekalsoom Malik, et al.
Oral Oncology|July 4, 2012
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Mimi Kim, Catherine Sarta, et al.
Oncotarget|February 8, 2019
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1Thomas J Ow, Cory D Fulcher, Carlos Thomas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphomaMuhammad R Abbasi, Joseph A Sparano, Catherine Sarta, et al.
The Laryngoscope|January 10, 2013
Transoral robotic total laryngectomyRichard V Smith, Bradley A Schiff, Catherine Sarta, et al.
Head & Neck|March 11, 2008
High-dose-rate brachytherapy plus neck dissection for nodal diseaseJonathan J Beitler, Madhur Garg, Randall P Owen, et al.
Oral Oncology|July 30, 2013
Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse populationAshish A Ankola, Richard V Smith, Robert D Burk, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 14, 2015
Randomized Controlled Trial Assessing the Feasibility of Shortened Fasts in Intubated ICU Patients Undergoing TracheotomyNathan Gonik, Andrew Tassler, Thomas J Ow, et al.
Clinical Breast Cancer|March 17, 2004
Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancerJoshua P Raff, Lakshmi Rajdev, Umekalsoom Malik, et al.
Oral Oncology|July 4, 2012
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Mimi Kim, Catherine Sarta, et al.
Oncotarget|February 8, 2019
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1Thomas J Ow, Cory D Fulcher, Carlos Thomas, et al.
Pageof 1